{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T21:27:22Z","timestamp":1781386042748,"version":"3.54.1"},"reference-count":102,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2021,4,12]]},"abstract":"<jats:sec>\n<jats:title> Background:<\/jats:title>\n<jats:p>Onychomycosis is by far the most common finger or toe nail fungal infectious\ndisease caused by dermatophytes, non-dermatophytic molds or yeast. It accounts for 50% of\nthe total nail disorders, and affects patients physically, socially, and psychologically and can seriously\ninfluence their quality of life.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>Oral antifungals are routinely used to treat the nail fungal disease; however oral therapy\nis associated with severe side effects and longer treatment times. In recent years, drug delivery\ndirectly into the nail or nail bed has gained attention and various topical products have been tested\nthat can cure the disease when applied topically or transungually. Nevertheless, drug penetration into\nand through the nail is not straightforward and requires chemicals to improve its permeability or\nby applying physical stress to promote drug penetration into and through the nail. This lucid review\npresents an overview of various causes of onychomycosis, current therapeutic approaches,\nand efforts aimed at increasing the permeability of nails through various strategies such as chemical,\nphysical and mechanical methods for permeation enhancement.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Various strategies have been proposed for the treatment of onychomycosis, however,\nmuch research into a more precise and effective therapy is still required.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2589977512666200731171505","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T16:56:38Z","timestamp":1596214598000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue"],"prefix":"10.2174","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-6525","authenticated-orcid":true,"given":"Rabia","family":"Aslam","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0465-9713","authenticated-orcid":true,"given":"Talib","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-9474","authenticated-orcid":true,"given":"Abid Mehmood","family":"Yousaf","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-6648","authenticated-orcid":true,"given":"Muhammad U.","family":"Ghori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-0180","authenticated-orcid":true,"given":"Ikram U.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-5672","authenticated-orcid":true,"given":"Syed A.A.","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Hampton University School of Pharmacy, Hampton University, VA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-2954","authenticated-orcid":true,"given":"Yasser","family":"Shahzad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1439-0507.2012.02199.x","volume":"55","author":"Grover C.","year":"2012","unstructured":"Grover C.; Khurana A.; An update on treatment of onychomycosis. Mycoses 2012,55(6),541-551","journal-title":"Mycoses"},{"key":"ref=2","first-page":"1263","volume":"12","author":"Daniel R.C.","year":"2013","unstructured":"Daniel R.C.; Onychomycosis: Burden of disease and the role of topical antifungal treatment. J Drugs Dermatol 2013,12(11),1263-1266","journal-title":"J Drugs Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1128\/CMR.11.3.415","volume":"11","author":"Elewski B.E.","year":"1998","unstructured":"Elewski B.E.; Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 1998,11(3),415-429","journal-title":"Clin Microbiol Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e4380","DOI":"10.1136\/bmj.e4380","volume":"344","author":"Moriarty B","year":"2012","unstructured":"Moriarty B; Hay R; Morris-Jones R; The diagnosis and management of tinea. BMJ 2012,344(7865),e4380","journal-title":"BMJ"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/jps.21025","volume":"97","author":"Hao J.","year":"2008","unstructured":"Hao J.; Li S.K.; Transungual iontophoretic transport of polar neutral and positively charged model permeants: Effects of electrophoresis and electroosmosis. J Pharm Sci 2008,97(2),893-905","journal-title":"J Pharm Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"100920","DOI":"10.1016\/j.mycmed.2019.100920","volume":"30","author":"Shokoohi G.R.","year":"2020","unstructured":"Shokoohi G.R.; Ansari S.; Abolghazi A.; Gramishoar M.; Nouripour-Sisakht S.; Mirhendi H.; Makimura K.; The first case of fingernail onychomycosis due to Neoscytalidium novaehollandiae, molecular identification and antifungal susceptibility. J Mycol Med 2020,30(1),100920","journal-title":"J Mycol Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01288.x","volume":"19","author":"Hay R.","year":"2005","unstructured":"Hay R.; Literature review. Onychomycosis. J Eur Acad Dermatol Venereol 2005,19(Suppl. 1),1-7","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","volume":"35","author":"Thomas J.","year":"2010","unstructured":"Thomas J.; Jacobson G.A.; Narkowicz C.K.; Peterson G.M.; Burnet H.; Sharpe C.; Toenail onychomycosis: An important global disease burden. J Clin Pharm Ther 2010,35(5),497-519","journal-title":"J Clin Pharm Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/17425247.2018.1518425","volume":"15","author":"Brown M.","year":"2018","unstructured":"Brown M.; Turner R.; Wevrett S.R.; Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders. Expert Opin Drug Deliv 2018,15(10),983-989","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.clindermatol.2013.06.006","volume":"31","author":"de Berker D.","year":"2013","unstructured":"de Berker D.; Nail anatomy. Clin Dermatol 2013,31(5),509-515","journal-title":"Clin Dermatol"},{"key":"ref=11","first-page":"1025","volume":"46","author":"Garson J.C.","year":"2000","unstructured":"Garson J.C.; Baltenneck F.; Leroy F.; Riekel C.; M\u00fcller M.; Histological structure of human nail as studied by synchrotron X-ray microdiffraction. Cell Mol Biol 2000,46(6),1025-1034","journal-title":"Cell Mol Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00406540","volume":"269","author":"Dawber R.P.R.","year":"1980","unstructured":"Dawber R.P.R.; The ultrastructure and growth of human nails. Arch Dermatol Res 1980,269(2),197-204","journal-title":"Arch Dermatol Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2133.1989.tb15511.x","volume":"121","author":"Jemec G.B.E.","year":"1989","unstructured":"Jemec G.B.E.; Agner T.; Serup J.; Transonychial water loss: Relation to sex, age and nail-plate thickness. Br J Dermatol 1989,121(4),443-446","journal-title":"Br J Dermatol"},{"key":"ref=14","first-page":"106","author":"Cohen J.L.","year":"1992","unstructured":"Cohen J.L.; Scher R.K.; Pappert A.S.;  Cutaneous fungal infections New York Igaku-Shoin Inc 1992,106-122","journal-title":"Cutaneous fungal infections New York Igaku-Shoin Inc"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","volume":"236","author":"Murdan S.","year":"2002","unstructured":"Murdan S.; Drug delivery to the nail following topical application. Int J Pharm 2002,236(1-2),1-26","journal-title":"Int J Pharm"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1211\/0022357991772448","volume":"51","author":"Kobayashi Y.","year":"1999","unstructured":"Kobayashi Y.; Miyamoto M.; Sugibayashi K.; Morimoto Y.; Drug permeation through the three layers of the human nail plate. J Pharm Pharmacol 1999,51(3),271-278","journal-title":"J Pharm Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1467-2494.2007.00372.x","volume":"29","author":"de Berker D.A.","year":"2007","unstructured":"de Berker D.A.; Andr\u00e9 J.; Baran R.; Nail biology and nail science. Int J Cosmet Sci 2007,29(4),241-275","journal-title":"Int J Cosmet Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.2042-7158.1985.tb04966.x","volume":"37","author":"Walters K.A.","year":"1985","unstructured":"Walters K.A.; Flynn G.L.; Marvel J.R.; Physicochemical characterization of the human nail: Solvent effects on the permeation of homologous alcohols. J Pharm Pharmacol 1985,37(11),771-775","journal-title":"J Pharm Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2133.2000.03246.x","volume":"142","author":"De Berker D.","year":"2000","unstructured":"De Berker D.; Wojnarowska F.; Sviland L.; Westgate G.E.; Dawber R.P.; Leigh I.M.; Keratin expression in the normal nail unit: Markers of regional differentiation. Br J Dermatol 2000,142(1),89-96","journal-title":"Br J Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","volume":"80","author":"Lipner S.R.","year":"2019","unstructured":"Lipner S.R.; Scher R.K.; Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol 2019,80(4),853-867","journal-title":"J Am Acad Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","volume":"57","author":"Jiaravuthisan M.M.","year":"2007","unstructured":"Jiaravuthisan M.M.; Sasseville D.; Vender R.B.; Murphy F.; Muhn C.Y.; Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007,57(1),1-27","journal-title":"J Am Acad Dermatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","volume":"65","author":"Hay R.J.","year":"2011","unstructured":"Hay R.J.; Baran R.; Onychomycosis: A proposed revision of the clinical classification. J Am Acad Dermatol 2011,65(6),1219-1227","journal-title":"J Am Acad Dermatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2133.1988.tb01749.x","volume":"118","author":"Hay R.J.","year":"1988","unstructured":"Hay R.J.; Baran R.; Moore M.K.; Wilkinson J.D.; Candida onychomycosis-An evaluation of the role of Candida species in nail disease. Br J Dermatol 1988,118(1),47-58","journal-title":"Br J Dermatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","volume":"13","author":"Gupta A.K.","year":"2012","unstructured":"Gupta A.K.; Simpson F.C.; New therapeutic options for onychomycosis. Expert Opin Pharmacother 2012,13(8),1131-1142","journal-title":"Expert Opin Pharmacother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","volume":"31","author":"Gupta A.K.","year":"2013","unstructured":"Gupta A.K.; Paquet M.; Simpson F.C.; Therapies for the treatment of onychomycosis. Clin Dermatol 2013,31(5),544-554","journal-title":"Clin Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0378-5173(02)00321-6","volume":"245","author":"Repka M.A.","year":"2002","unstructured":"Repka M.A.; O\u2019Haver J.; See C.H.; Gutta K.; Munjal M.; Nail morphology studies as assessments for onychomycosis treatment modalities. Int J Pharm 2002,245(1-2),25-36","journal-title":"Int J Pharm"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0190-9622(99)70397-X","volume":"40","author":"Scher RK","year":"1999","unstructured":"Scher RK; Onychomycosis: Therapeutic update. J Am Acad Dermatol 1999,40(6),S21-S6","journal-title":"J Am Acad Dermatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ejps.2012.12.014","volume":"48","author":"Tanr\u0131verdi S.T.","year":"2013","unstructured":"Tanr\u0131verdi S.T.; \u00d6zer \u00d6.; Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. Eur J Pharm Sci 2013,48(4-5),628-636","journal-title":"Eur J Pharm Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpharm.2012.04.024","volume":"435","author":"Walters K.A.","year":"2012","unstructured":"Walters K.A.; Abdalghafor H.M.; Lane M.E.; The human nail--barrier characterisation and permeation enhancement. Int J Pharm 2012,435(1),10-21","journal-title":"Int J Pharm"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.11.009","volume":"370","author":"Brown M.B.","year":"2009","unstructured":"Brown M.B.; Khengar R.H.; Turner R.B.; Forbes B.; Traynor M.J.; Evans C.R.; Jones S.A.; Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement. Int J Pharm 2009,370(1-2),61-67","journal-title":"Int J Pharm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s11095-009-9854-x","volume":"26","author":"Smith K.A.","year":"2009","unstructured":"Smith K.A.; Hao J.; Li S.K.; Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail. Pharm Res 2009,26(6),1446-1455","journal-title":"Pharm Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1517\/17425240802497218","volume":"5","author":"Murdan S.","year":"2008","unstructured":"Murdan S.; Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv 2008,5(11),1267-1282","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sder.2008.12.003","volume":"28","year":"2009","unstructured":"de Berker. Management of psoriatic nail disease. Semin Cutan Med Surg 2009,28(1),39-43","journal-title":"Semin Cutan Med Surg"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejps.2003.11.008","volume":"21","author":"Kobayashi Y.","year":"2004","unstructured":"Kobayashi Y.; Komatsu T.; Sumi M.; Numajiri S.; Miyamoto M.; Kobayashi D.; Sugibayashi K.; Morimoto Y.; \n                        In vitro permeation of several drugs through the human nail plate: Relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci 2004,21(4),471-477","journal-title":"Eur J Pharm Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2133.1998.02050.x","volume":"138","author":"Roberts D.T.","year":"1998","unstructured":"Roberts D.T.; Evans E.G.; Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998,138(1),189-190","journal-title":"Br J Dermatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1208\/s12249-019-1591-9","volume":"21","author":"Vikas A.","year":"2020","unstructured":"Vikas A.; Rashmin P.; Mrunali P.; Chavan R.B.; Kaushik T.; mechanistic insights of formulation approaches for the treatment of nail infection: Conventional and novel drug delivery approaches. AAPS PharmSciTech 2020,21(2),67","journal-title":"AAPS PharmSciTech"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","volume":"35","author":"Walters K.A.","year":"1983","unstructured":"Walters K.A.; Flynn G.L.; Marvel J.R.; Physicochemical characterization of the human nail: Permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum. J Pharm Pharmacol 1983,35(1),28-33","journal-title":"J Pharm Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1002\/jps.22590","volume":"100","author":"Smith K.A.","year":"2011","unstructured":"Smith K.A.; Hao J.; Li S.K.; Effects of organic solvents on the barrier properties of human nail. J Pharm Sci 2011,100(10),4244-4257","journal-title":"J Pharm Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejps.2007.07.009","volume":"32","author":"Gunt H.B.","year":"2007","unstructured":"Gunt H.B.; Kasting G.B.; Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci 2007,32(4-5),254-260","journal-title":"Eur J Pharm Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/jps.20159","volume":"93","author":"Hui X.","year":"2004","unstructured":"Hui X.; Wester R.C.; Barbadillo S.; Lee C.; Patel B.; Wortzmman M.; Gans E.H.; Maibach H.I.; Ciclopirox delivery into the human nail plate. J Pharm Sci 2004,93(10),2545-2548","journal-title":"J Pharm Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/pharmaceutics10030156","volume":"10","author":"Cutr\u00edn-G\u00f3mez E.","year":"2018","unstructured":"Cutr\u00edn-G\u00f3mez E.; Anguiano-Igea S.; Delgado-Charro M.B.; G\u00f3mez-Amoza J.L.; Otero-Espinar F.J.; effect on nail structure and transungual permeability of the ethanol and poloxamer ratio from cyclodextrin-soluble polypseudorotaxanes based nail lacquer. Pharmaceutics 2018,10(3),156","journal-title":"Pharmaceutics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jps.20757","volume":"96","author":"Narasimha Murthy S.","year":"2007","unstructured":"Narasimha Murthy S.; Wiskirchen D.E.; Bowers C.P.; Iontophoretic drug delivery across human nail. J Pharm Sci 2007,96(2),305-311","journal-title":"J Pharm Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jconrel.2014.11.017","volume":"199","author":"Elsayed M.M.","year":"2015","unstructured":"Elsayed M.M.; Development of topical therapeutics for management of onychomycosis and other nail disorders: A pharmaceutical perspective. J Control Release 2015,199,132-144","journal-title":"J Control Release"},{"key":"ref=44","first-page":"252","volume":"3","author":"Shanbhag P.P.","year":"2017","unstructured":"Shanbhag P.P.; Jani U.; Drug delivery through nails: Present and future. New Horiz Transl Med 2017,3(5),252-263","journal-title":"New Horiz Transl Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","volume":"49","author":"Mertin D.","year":"1997","unstructured":"Mertin D.; Lippold B.C.; In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: Prediction of the penetration rate of antimycotics through the nail plate and their efficacy. J Pharm Pharmacol 1997,49(9),866-872","journal-title":"J Pharm Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/jps.21984","volume":"99","author":"Smith K.A.","year":"2010","unstructured":"Smith K.A.; Hao J.; Li S.K.; Influence of pH on transungual passive and iontophoretic transport. J Pharm Sci 2010,99(4),1955-1967","journal-title":"J Pharm Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdermsci.2006.12.010","volume":"46","author":"Murthy S.N.","year":"2007","unstructured":"Murthy S.N.; Waddell D.C.; Shivakumar H.N.; Balaji A.; Bowers C.P.; Iontophoretic permselective property of human nail. J Dermatol Sci 2007,46(2),150-152","journal-title":"J Dermatol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/03639045.2011.637931","volume":"38","author":"Shivakumar H.N.","year":"2012","unstructured":"Shivakumar H.N.; Juluri A.; Desai B.G.; Murthy S.N.; Ungual and transungual drug delivery. Drug Dev Ind Pharm 2012,38(8),901-911","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3109\/1061186X.2014.929138","volume":"22","author":"Saner M.V.","year":"2014","unstructured":"Saner M.V.; Kulkarni A.D.; Pardeshi C.V.; Insights into drug delivery across the nail plate barrier. J Drug Target 2014,22(9),769-789","journal-title":"J Drug Target"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0928-0987(97)00270-4","volume":"5","author":"Van Hoogdalem E.","year":"1997","unstructured":"Van Hoogdalem E.; Van den Hoven W.; Terpstra I.; Van Zijtveld J.; Verschoor J.; Visser J.; Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine. Eur J Pharm Sci 1997,5(3),119-127","journal-title":"Eur J Pharm Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jps.10291","volume":"92","author":"Hui X.","year":"2003","unstructured":"Hui X.; Chan T.C.; Barbadillo S.; Lee C.; Maibach H.I.; Wester R.C.; Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane. J Pharm Sci 2003,92(1),142-148","journal-title":"J Pharm Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijpharm.2006.09.042","volume":"332","author":"Mohor\u010di\u010d M.","year":"2007","unstructured":"Mohor\u010di\u010d M.; Torkar A.; Friedrich J.; Kristl J.; Murdan S.; An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int J Pharm 2007,332(1-2),196-201","journal-title":"Int J Pharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1211\/jpp.61.04.0003","volume":"61","author":"Nair A.B.","year":"2009","unstructured":"Nair A.B.; Sammeta S.M.; Vaka S.R.K.; Narasimha Murthy S.; A study on the effect of inorganic salts in transungual drug delivery of terbinafine. J Pharm Pharmacol 2009,61(4),431-437","journal-title":"J Pharm Pharmacol"},{"key":"ref=54","first-page":"461","volume":"55","author":"Angelo T.","year":"2017","unstructured":"Angelo T.; Borgheti-Cardoso L.N.; Gelfuso G.M.; Taveira S.F.; Gratieri T.; Chemical and physical strategies in onychomycosis topical treatment: A review. Med Mycol 2017,55(5),461-475","journal-title":"Med Mycol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s12272-016-0774-0","volume":"39","author":"Thapa R.K.","year":"2016","unstructured":"Thapa R.K.; Choi J.Y.; Go T.G.; Kang M.H.; Han S.D.; Jun J-H.; Son M.W.; Yong C.S.; Kim J.O.; Development of ciclopirox nail lacquer with enhanced permeation and retention. Arch Pharm Res 2016,39(7),953-959","journal-title":"Arch Pharm Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1208\/s12249-017-0917-8","volume":"19","author":"Khattab A.","year":"2018","unstructured":"Khattab A.; Shalaby S.; optimized ciclopirox-based eudragit rlpo nail lacquer: Effect of endopeptidase enzyme as permeation enhancer on transungual drug delivery and efficiency against onychomycosis. AAPS PharmSciTech 2018,19(3),1048-1060","journal-title":"AAPS PharmSciTech"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.06.010","volume":"282","author":"Repka M.A.","year":"2004","unstructured":"Repka M.A.; Mididoddi P.K.; Stodghill S.P.; Influence of human nail etching for the assessment of topical onychomycosis therapies. Int J Pharm 2004,282(1-2),95-106","journal-title":"Int J Pharm"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jconrel.2004.12.005","volume":"103","author":"Donnelly R.F.","year":"2005","unstructured":"Donnelly R.F.; McCarron P.A.; Lightowler J.M.; Woolfson A.D.; Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release 2005,103(2),381-392","journal-title":"J Control Release"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00128071-200607040-00007","volume":"7","author":"Susilo R.","year":"2006","unstructured":"Susilo R.; Korting H.C.; Greb W.; Strauss U.P.; Nail penetration of sertaconazole with a sertaconazole-containing nail patch formulation. Am J Clin Dermatol 2006,7(4),259-262","journal-title":"Am J Clin Dermatol"},{"key":"ref=60","author":"Boker A.","year":"2007","unstructured":"Boker A.; Bea Y.; Gowrishankar T.; A double-blind, placebo-controlled, pilot study of 1% terbinafine cream delivered via toenail microconduits for the treatment of subungual onychomycosis. 65th annual meeting of the American Academy of Dermatology 2007","journal-title":"65th annual meeting of the American Academy of Dermatology"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03639045.2010.491832","volume":"37","author":"Vaka S.R.K.","year":"2011","unstructured":"Vaka S.R.K.; Murthy S.N.; O\u2019Haver J.H.; Repka M.A.; A platform for predicting and enhancing model drug delivery across the human nail plate. Drug Dev Ind Pharm 2011,37(1),72-79","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3109\/03639045.2015.1033426","volume":"41","author":"Kushwaha A.","year":"2015","unstructured":"Kushwaha A.; Murthy R.N.; Murthy S.N.; Elkeeb R.; Hui X.; Maibach H.I.; Emerging therapies for the treatment of ungual onychomycosis. Drug Dev Ind Pharm 2015,41(10),1575-1581","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2133.2007.08014.x","volume":"157","author":"Grover C.","year":"2007","unstructured":"Grover C.; Bansal S.; Nanda S.; Reddy B.S.; Kumar V.; Combination of surgical avulsion and topical therapy for single nail onychomycosis: A randomized controlled trial. Br J Dermatol 2007,157(2),364-368","journal-title":"Br J Dermatol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","volume":"357","author":"Hao J.","year":"2008","unstructured":"Hao J.; Smith K.A.; Li S.K.; Chemical method to enhance transungual transport and iontophoresis efficiency. Int J Pharm 2008,357(1-2),61-69","journal-title":"Int J Pharm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1002\/jps.21711","volume":"98","author":"Nair A.B.","year":"2009","unstructured":"Nair A.B.; Kim H.D.; Chakraborty B.; Singh J.; Zaman M.; Gupta A.; Friden P.M.; Murthy S.N.; Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci 2009,98(11),4130-4140","journal-title":"J Pharm Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpharm.2009.03.012","volume":"375","author":"Nair A.B.","year":"2009","unstructured":"Nair A.B.; Sammeta S.M.; Kim H.D.; Chakraborty B.; Friden P.M.; Murthy S.N.; Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm 2009,375(1-2),22-27","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1248\/cpb.46.1797","volume":"46","author":"Kobayashi Y.","year":"1998","unstructured":"Kobayashi Y.; Miyamoto M.; Sugibayashi K.; Morimoto Y.; Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate. Chem Pharm Bull (Tokyo) 1998,46(11),1797-1802","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jps.10058","volume":"91","author":"Malhotra G.G.","year":"2002","unstructured":"Malhotra G.G.; Zatz J.L.; Investigation of nail permeation enhancement by chemical modification using water as a probe. J Pharm Sci 2002,91(2),312-323","journal-title":"J Pharm Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2009.11.019","volume":"386","author":"Vejnovic I.","year":"2010","unstructured":"Vejnovic I.; Simmler L.; Betz G.; Investigation of different formulations for drug delivery through the nail plate. Int J Pharm 2010,386(1-2),185-194","journal-title":"Int J Pharm"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1389450116666151019095121","volume":"17","author":"Borgheti-Cardoso L.N.","year":"2016","unstructured":"Borgheti-Cardoso L.N.; \u00c2ngelo T.; Gelfuso G.M.; Topical and transdermal delivery of drug-loaded nano\/microsystems with application of physical enhancement techniques. Curr Drug Targets 2016,17(13),1545-1559","journal-title":"Curr Drug Targets"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2014008464","volume":"31","author":"Barot BS","year":"2014","unstructured":"Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK; Drug delivery to the nail: Therapeutic options and challenges for onychomycosis critical reviews\u2122 in therapeutic drug carrier systems 2014,31(6)","journal-title":"critical reviews\u2122 in therapeutic drug carrier systems"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/03639040600683410","volume":"32","author":"Mididoddi P.K.","year":"2006","unstructured":"Mididoddi P.K.; Prodduturi S.; Repka M.A.; Influence of tartaric acid on the bioadhesion and mechanical properties of hot-melt extruded hydroxypropyl cellulose films for the human nail. Drug Dev Ind Pharm 2006,32(9),1059-1066","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1389450116666151019095121","volume":"17","author":"Borgheti-Cardoso L.N.","year":"2016","unstructured":"Borgheti-Cardoso L.N.; \u00c2ngelo T.; Gelfuso G.M.; Lopez R.F.; Gratieri T.; Topical and transdermal delivery of drug-loaded nano\/ microsystems with application of physical enhancement techniques. Curr Drug Targets 2016,17(13),1545-1559","journal-title":"Curr Drug Targets"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0190-9622(96)80069-7","volume":"34","author":"Kassan D.G.","year":"1996","unstructured":"Kassan D.G.; Lynch A.M.; Stiller M.J.; Physical enhancement of dermatologic drug delivery: Iontophoresis and phonophoresis. J Am Acad Dermatol 1996,34(4),657-666","journal-title":"J Am Acad Dermatol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/bjo.2004.048314","volume":"89","author":"Horwath-Winter J.","year":"2005","unstructured":"Horwath-Winter J.; Schmut O.; Haller-Schober E.M.; Gruber A.; Rieger G.; Iodide iontophoresis as a treatment for dry eye syndrome. Br J Ophthalmol 2005,89(1),40-44","journal-title":"Br J Ophthalmol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/00005768-200208000-00010","volume":"34","author":"Nowicki K.","year":"2002","unstructured":"Nowicki K.; Hummer C.D.; Heidt R.S.; Colosimo A.J.; Effects of iontophoretic versus injection administration of dexamethasone. Med Sci Sports Exerc 2002,34(8),1294-1301","journal-title":"Med Sci Sports Exerc"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jdent.2008.04.018","volume":"36","author":"Chen L-J.","year":"2008","unstructured":"Chen L-J.; Meng Q-F.; Chen Y-M.; Smales R.J.; Yip K.H.; Effect of fluoride iontophoresis on the microtensile bond strength between dentin and two adhesive systems. J Dent 2008,36(9),697-702","journal-title":"J Dent"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","volume":"4","author":"Darkes M.J.","year":"2003","unstructured":"Darkes M.J.; Scott L.J.; Goa K.L.; Terbinafine: A review of its use in onychomycosis in adults. Am J Clin Dermatol 2003,4(1),39-65","journal-title":"Am J Clin Dermatol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/jps.21555","volume":"98","author":"Nair A.B.","year":"2009","unstructured":"Nair A.B.; Vaka S.R.; Sammeta S.M.; Kim H.D.; Friden P.M.; Chakraborty B.; Murthy S.N.; Trans- ungual iontophoretic delivery of terbinafine. J Pharm Sci 2009,98(5),1788-1796","journal-title":"J Pharm Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/1872211313666191030155837","volume":"13","author":"Kreutz T.","year":"2019","unstructured":"Kreutz T.; de Matos S.P.; Koester L.S.; Recent patents on permeation enhancers for drug delivery through nails. Recent Pat Drug Deliv Formul 2019,13(3),203-218","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.clindermatol.2013.06.010","volume":"31","author":"Gupta A.K.","year":"2013","unstructured":"Gupta A.K.; Paquet M.; Improved efficacy in onychomycosis therapy. Clin Dermatol 2013,31(5),555-563","journal-title":"Clin Dermatol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1346-8138.2007.00310.x","volume":"34","author":"Sumikawa M.","year":"2007","unstructured":"Sumikawa M.; Egawa T.; Honda I.; Yamamoto Y.; Sumikawa Y.; Kubota M.; Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis. J Dermatol 2007,34(7),456-464","journal-title":"J Dermatol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ajem.2006.03.029","volume":"24","author":"Salter S.A.","year":"2006","unstructured":"Salter S.A.; Ciocon D.H.; Gowrishankar T.R.; Kimball A.B.; Controlled nail trephination for subungual hematoma. Am J Emerg Med 2006,24(7),875-877","journal-title":"Am J Emerg Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2015.10.026","volume":"220","author":"Chiu W.S.","year":"2015","unstructured":"Chiu W.S.; Belsey N.A.; Garrett N.L.; Moger J.; Price G.J.; Delgado-Charro M.B.; Guy R.H.; Drug delivery into microneedle-porated nails from nanoparticle reservoirs. J Control Release 2015,220(Pt A),98-106","journal-title":"J Control Release"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.3390\/pharmaceutics11010029","volume":"11","author":"Cordoba D\u00edaz D.","year":"2019","unstructured":"Cordoba D\u00edaz D.; Losa Iglesias M.E.; Becerro de Bengoa Vallejo R.; Cordoba Diaz M.; Transungual delivery of ciclopirox is increased 3-4 fold by mechanical fenestration of human nail plate in an in vitro model. Pharmaceutics 2019,11(1),E29","journal-title":"Pharmaceutics"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ma12071028","volume":"12","author":"\u0160veikauskait\u0117 I.","year":"2019","unstructured":"\u0160veikauskait\u0117 I.; Pockevi\u010dius A.; Briedis V.; Potential of chemical and physical enhancers for transungual delivery of amorolfine hydrochloride. Materials (Basel) 2019,12(7),1028","journal-title":"Materials (Basel)"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2017.09.048","volume":"544","author":"Nguyen H.X.","year":"2018","unstructured":"Nguyen H.X.; Banga A.K.; Effect of ablative laser on in vitro transungual delivery. Int J Pharm 2018,544(2),402-414","journal-title":"Int J Pharm"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2015.01.019","volume":"202","author":"Shahzad Y.","year":"2015","unstructured":"Shahzad Y.; Louw R.; Gerber M.; du Plessis J.; Breaching the skin barrier through temperature modulations. J Control Release 2015,202,1-13","journal-title":"J Control Release"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00340-005-2036-6","volume":"81","author":"Vogel A.","year":"2005","unstructured":"Vogel A.; Noack J.; H\u00fcttman G.; Paltauf G.; Mechanisms of femtosecond laser nanosurgery of cells and tissues. Appl Phys B 2005,81(8),1015-1047","journal-title":"Appl Phys B"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1109\/2944.577301","volume":"2","author":"Neev J.","year":"1996","unstructured":"Neev J.; Silva L.B.D.; Feit M.D.; Perry M.D.; Rubenchik A.M.; Stuart B.C.; Ultrashort pulse lasers for hard tissue ablation. IEEE J Sel Top Quantum Electron 1996,2(4),790-800","journal-title":"IEEE J Sel Top Quantum Electron"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s13346-019-00638-x","volume":"9","author":"Vanstone S.","year":"2019","unstructured":"Vanstone S.; Stone J.M.; Gordeev S.N.; Guy R.H.; Mechanism of human nail poration by high-repetition-rate, femtosecond laser ablation. Drug Deliv Transl Res 2019,9(5),956-967","journal-title":"Drug Deliv Transl Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"72-7","DOI":"10.1016\/j.jconrel.2017.10.014","volume":"268","author":"Vanstone S","year":"2017","unstructured":"Vanstone S; Cordery SF; Stone JM; Gordeev SN; Guy RH; Precise laser poration to control drug delivery into and through human nail. J Control Release 2017,268,72-7","journal-title":"J Control Release"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2014008464","volume":"31","year":"2014","unstructured":"Barot BS, Parejiya PB, Patel HK, Mehta DM, Shelat PK. Drug delivery to the nail: Therapeutic options and challenges for onychomycosis Crit Rev Ther Drug Carrier Syst 2014,31(6),459-94","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.7863\/jum.2011.30.12.1723","volume":"30","author":"Abadi D.","year":"2011","unstructured":"Abadi D.; Zderic V.; Ultrasound-mediated nail drug delivery system. J Ultrasound Med 2011,30(12),1723-1730","journal-title":"J Ultrasound Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1473-2130.2004.00095.x","volume":"2","author":"Di Chiacchio N.","year":"2003","unstructured":"Di Chiacchio N.; Kadunc B.V.; de Almeida A.R.T.; Madeira C.L.; Nail abrasion. J Cosmet Dermatol 2003,2(3-4),150-152","journal-title":"J Cosmet Dermatol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1346-8138.1990.tb03023.x","volume":"17","author":"Maeda N.","year":"1990","unstructured":"Maeda N.; Mizuno N.; Ichikawa K.; Nail abrasion: A new treatment for ingrown toe-nails. J Dermatol 1990,17(12),746-749","journal-title":"J Dermatol"},{"key":"ref=97","author":"Richert B.","year":"2020","unstructured":"Richert B.;  Onychomycosis 2020","journal-title":"Onychomycosis"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.002","volume":"384","author":"Elkeeb R.","year":"2010","unstructured":"Elkeeb R.; AliKhan A.; Elkeeb L.; Hui X.; Maibach H.I.; Transungual drug delivery: Current status. Int J Pharm 2010,384(1-2),1-8","journal-title":"Int J Pharm"},{"key":"ref=99","first-page":"356","volume":"139","author":"Effendy I","year":"1989","unstructured":"Effendy I; Kolczak H; Friederich H; Noncompliance relevant variables in patients with onychomycosis. Wien Med Wochenschr 1989,139(15-16),356-6","journal-title":"Wien Med Wochenschr"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/myc.12032","volume":"56","author":"Succi I.B.","year":"2013","unstructured":"Succi I.B.; Bernardes-Engemann A.R.; Orofino-Costa R.; Intermittent therapy with terbinafine and nail abrasion for dermatophyte toe onychomycosis: A pilot study. Mycoses 2013,56(3),327-332","journal-title":"Mycoses"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7547\/87507315-81-1-28","volume":"81","author":"Hettinger D.F.","year":"1991","unstructured":"Hettinger D.F.; Valinsky M.S.; Treatment of onychomycosis with nail avulsion and topical ketoconazole. J Am Podiatr Med Assoc 1991,81(1),28-32","journal-title":"J Am Podiatr Med Assoc"},{"key":"ref=102","first-page":"29","volume":"12","author":"Kawa N.","year":"2019","unstructured":"Kawa N.; Lee K.C.; Anderson R.R.; Garibyan L.; Onychomycosis: A review of new and emerging topical and device-based treatments. J Clin Aesthet Dermatol 2019,12(10),29-34","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184448\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T15:08:46Z","timestamp":1634396926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184448\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977512666200731171505","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}